Clinical trial

A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol…

NCT00274560 · Boehringer Ingelheim, Industry · Completed

Key facts

NCT number NCT00274560
Title A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol.
Official title A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol in a 12 Week, Randomized, Double-Blind, Double-Dummy Parallel Group Study in Patients With Chronic Obstructive Pulmonary Disease (COPD).
Lead sponsor Boehringer Ingelheim, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Pulmonary Disease, Chronic Obstructive
Intervention type Drug
Interventions Tiotropium, Salmeterol
Enrollment 653
Start date May 1, 2002
Primary completion Mar 27, 2003
First posted Jan 11, 2006
Last update posted Dec 1, 2023
Countries Finland, Greece, Italy, Portugal, Sweden, Turkey (Türkiye), United Kingdom, United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies